Skip to main content
Premium Trial:

Request an Annual Quote

DNAStar Names Inqaba Biotec as Distributor for Africa

NEW YORK – DNAStar has appointed Inqaba Biotechnical Industries as distributor of its DNA, RNA, and protein sequence analysis software in Africa.

DNAStar, based in Madison, Wisconsin, offers the Lasergene software suite, which provides molecular biologists, geneticists, and structural biologists with capabilities such as Sanger and next-generation sequencing assembly and analysis, protein sequence and structure analysis, and protein structure prediction.

Inqaba, a South African genomics company established in 2002, provides a wide array of products and services to the life sciences market in sub-Saharan Africa.

Inqaba has "a long history of successfully meeting the needs of molecular biologists in Africa, including meeting their software needs," Tom Schwei, vice president and general manager of DNAStar, said in a statement. "We have great confidence in Inqaba Biotec to support African customers with outstanding sales and customer service for our Lasergene software."

Financial terms were not disclosed.

In August, DNAStar said it had appointed Ships Bioscience as a nonexclusive but sole distributor of its products in Japan.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.